BR0116249A - Vacina de bacterina de mycoplasma hyopneumoniae aperfeiçoada - Google Patents

Vacina de bacterina de mycoplasma hyopneumoniae aperfeiçoada

Info

Publication number
BR0116249A
BR0116249A BR0116249-7A BR0116249A BR0116249A BR 0116249 A BR0116249 A BR 0116249A BR 0116249 A BR0116249 A BR 0116249A BR 0116249 A BR0116249 A BR 0116249A
Authority
BR
Brazil
Prior art keywords
mycoplasma hyopneumoniae
hyopneumoniae bacterin
vaccine
immunity
provides
Prior art date
Application number
BR0116249-7A
Other languages
English (en)
Other versions
BRPI0116249B1 (pt
Inventor
Hsien-Jue Steve Chu
Wumin Li
Zhichang Xu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22972978&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0116249(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0116249A publication Critical patent/BR0116249A/pt
Publication of BRPI0116249B1 publication Critical patent/BRPI0116249B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

"VACINA DE BACTERINA DE MYCOPLASMA HYOPNEUMONIAE APERFEIçOADA". A invenção provê uma composição de vacina de bacterina de Mycoplasma hyopneumoniae aperfeiçoada, que vantajosamente provê imunidade contra infecção depois de uma única administração. A composição compreende uma bacterina de Mycoplasma hyopneumoniae inativada e uma mistura auxiliar, que, em combinação, provê imunidade contra infecção de Mycoplasma hyopneumoniae depois de única administração, e elicia uma resposta imune específica para bacterina de Mycoplasma hyopneumoniae e incluindo imunidade mediada por célula e imunidade local (IgA secretória). Em uma concretização preferida, a mistura auxiliar comprende um polímero de ácido acrílico, mais de preferência Carbopol, e uma mistura de óleo metabolizável tais como um ou mais hidrocarbonetos de terpeno, de preferência esqualeno ou esqualano, e copolímero por blocos de polioxietileno-polipropileno tal como Pluronic<32>. A composição de vacina pode opcionalmente incluir um conservante, de preferência timerosol e/ou EDTA.
BRPI0116249A 2000-12-19 2001-12-11 composição de vacina para imunização de um animal contra infecção por mycoplasma hyopneumoniae e vacina BRPI0116249B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25663700P 2000-12-19 2000-12-19
PCT/US2001/047865 WO2002049666A2 (en) 2000-12-19 2001-12-11 Mycoplasma hyopneumoniae bacterin vaccine

Publications (2)

Publication Number Publication Date
BR0116249A true BR0116249A (pt) 2004-03-02
BRPI0116249B1 BRPI0116249B1 (pt) 2016-06-14

Family

ID=22972978

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0116249A BRPI0116249B1 (pt) 2000-12-19 2001-12-11 composição de vacina para imunização de um animal contra infecção por mycoplasma hyopneumoniae e vacina

Country Status (28)

Country Link
US (4) US20020131980A1 (pt)
EP (1) EP1343525B1 (pt)
JP (2) JP5074656B2 (pt)
KR (1) KR100874119B1 (pt)
CN (1) CN1296095C (pt)
AR (1) AR033410A1 (pt)
AT (1) ATE359813T1 (pt)
AU (2) AU2899302A (pt)
BG (1) BG66213B1 (pt)
BR (1) BRPI0116249B1 (pt)
CY (1) CY1106669T1 (pt)
CZ (1) CZ307075B6 (pt)
DE (1) DE60127994T2 (pt)
DK (1) DK1343525T3 (pt)
ES (1) ES2283452T3 (pt)
HK (1) HK1056513A1 (pt)
HR (1) HRP20030585B1 (pt)
HU (1) HU227431B1 (pt)
ME (1) ME00570B (pt)
MX (1) MXPA03005357A (pt)
MY (1) MY129765A (pt)
NZ (1) NZ526904A (pt)
PL (1) PL211174B1 (pt)
PT (1) PT1343525E (pt)
RS (1) RS51536B (pt)
TW (1) TWI308872B (pt)
WO (1) WO2002049666A2 (pt)
ZA (1) ZA200305545B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
GB0400264D0 (en) * 2004-01-07 2004-02-11 Polytherics Ltd Complexes
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
PT3320919T (pt) 2005-12-29 2020-09-03 Boehringer Ingelheim Animal Health Usa Inc Composições imunogénicas de pcv2 multivalentes e métodos para produzir composições deste tipo
PL2371382T3 (pl) 2005-12-29 2016-08-31 Boehringer Ingelheim Vetmedica Inc Zastosowanie kompozycji immunogennej PCV2 do zmniejszania objawów klinicznych u świń
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
MX2009006066A (es) 2006-12-15 2009-06-17 Boehringer Ingelheim Vetmed Tratamiento de cerdos con el antigeno pcv.
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
DK2217271T3 (en) 2007-11-06 2016-06-06 Zoetis Services Llc Avirulent, live vaccine with adjuvant against Mycoplasma hyopneumoniae
US20090317423A1 (en) 2008-01-23 2009-12-24 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
MX2010014078A (es) * 2008-06-25 2011-04-11 Braasch Biotech Llc Composiciones y metodos para inmunogenecidad mejorada de somatostatina.
BRPI1010679B1 (pt) * 2009-05-19 2020-09-24 Bioproperties Pty Ltd Cepa de vacina de mycoplasma hyopneumoniae sensível à temperatura e aplicações da mesma, composiçao de vacina, método de preparaçao e uso da mesma
JP5968622B2 (ja) 2009-06-04 2016-08-10 国立感染症研究所長 マイコプラズマ感染症用ワクチン
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
DK2475384T3 (en) * 2009-09-10 2016-10-24 Merial Inc NEW VACCINE FORMULATIONS COMPREHENSIVE saponin-CONTAINING ADJUVANTS
CN102869379B (zh) 2010-04-30 2015-04-15 淡马锡生命科学研究院有限公司 H5n1谱系的通用疫苗
WO2013149017A1 (en) * 2012-03-28 2013-10-03 Kansas State University Research Foundation Vaccine adjuvant
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
CN103623400B (zh) * 2012-08-24 2016-08-17 普莱柯生物工程股份有限公司 抗猪支原体肺炎、传染性胸膜肺炎疫苗组合物及制备方法
CA2896293C (en) * 2012-12-28 2023-11-07 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition comprising mycoplasma antigens
EP2938747B1 (en) 2012-12-28 2019-05-01 Boehringer Ingelheim Vetmedica GmbH Method of making a mycoplasma vaccine
CN104338128B (zh) * 2013-07-31 2017-09-05 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
KR20220083861A (ko) 2013-10-02 2022-06-20 베링거 인겔하임 애니멀 헬스 유에스에이 인크. Ｐｃｖ2 ｏｒｆ2 단백질 변이체 및 이로 이루어진 바이러스 유사 입자
JP2021505560A (ja) * 2017-12-04 2021-02-18 インターベット インターナショナル ベー． フェー． イヌライム病ワクチン
CN108324941A (zh) * 2018-04-03 2018-07-27 林淑卿 猪疾病疫苗用佐剂及其制备方法
CN117100851A (zh) * 2023-10-23 2023-11-24 成都依思康生物科技有限公司 一种佐剂、疫苗组合物及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) * 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
EP0283085B1 (en) 1987-03-17 1992-11-11 Akzo N.V. Adjuvant mixture
JP2746272B2 (ja) * 1987-11-03 1998-05-06 シンテツクス（ユー エス エイ）インコーポレーテツド ワクチンアジュバント
US5240706A (en) * 1989-04-07 1993-08-31 Ml Technology Ventures, L.P. Intranasal administration of Mycoplasma hyopneumoniae antigen
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
WO1991018627A1 (en) 1990-05-29 1991-12-12 Smithkline Beecham Corporation Swine pneumonia vaccine and method for the preparation thereof
US5695769A (en) * 1990-06-13 1997-12-09 Pfizer Inc. Pasteurella multocida toxoid vaccines
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
JP3043809B2 (ja) 1991-11-15 2000-05-22 ファイザー・インコーポレイテッド グラム陰性菌ワクチン
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5534256A (en) * 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
JP3265095B2 (ja) * 1993-11-19 2002-03-11 本田技研工業株式会社 キャニスタ
EP0968722B1 (en) * 1994-05-10 2007-06-20 Wyeth Improved modified live BRSV vaccine
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
DE19601754A1 (de) * 1996-01-19 1997-07-24 Hoechst Ag Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung
US5846735A (en) * 1996-04-18 1998-12-08 University Of Iowa Research Foundation Hepatitis C virus Fc-binding function
WO1998028333A2 (en) * 1996-12-20 1998-07-02 The Board Of Regents, The University Of Texas System USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS)
FR2775601B1 (fr) * 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
US6342231B1 (en) * 1998-07-01 2002-01-29 Akzo Nobel N.V. Haemophilus parasuis vaccine and diagnostic
US6632439B2 (en) * 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
ES2550458T3 (es) * 2001-07-02 2015-11-10 Zoetis Services Llc Vacuna monodosis con Mycoplasma hyopneumoniae
AU2003214387A1 (en) * 2002-03-07 2003-09-16 Biocompatibles Uk Limited Drug carriers comprising amphiphilic block copolymers
ITMI20030269A1 (it) * 2003-02-14 2004-08-15 Advance Holdings Ltd Sale di cetilpiridino di un agente antiinfiammatorio
US8052762B1 (en) * 2010-09-02 2011-11-08 Kelly Van Gogh, LLC Compositions for dyeing keratin-containing fibers

Also Published As

Publication number Publication date
ATE359813T1 (de) 2007-05-15
CN1296095C (zh) 2007-01-24
HRP20030585B1 (en) 2008-03-31
EP1343525A2 (en) 2003-09-17
ES2283452T3 (es) 2007-11-01
AR033410A1 (es) 2003-12-17
BG66213B1 (bg) 2012-05-31
DE60127994D1 (de) 2007-05-31
DK1343525T3 (da) 2007-06-04
US9238065B2 (en) 2016-01-19
ME00570A (en) 2011-12-20
BRPI0116249B1 (pt) 2016-06-14
MXPA03005357A (es) 2003-10-06
DE60127994T2 (de) 2008-01-17
CN1489472A (zh) 2004-04-14
JP2009073855A (ja) 2009-04-09
AU2899302A (en) 2002-07-01
WO2002049666A3 (en) 2003-02-06
HU227431B1 (en) 2011-06-28
MY129765A (en) 2007-04-30
US7666439B2 (en) 2010-02-23
HK1056513A1 (en) 2004-02-20
US20020131980A1 (en) 2002-09-19
HUP0400687A2 (hu) 2004-06-28
CZ20031721A3 (cs) 2004-04-14
PT1343525E (pt) 2007-07-12
HRP20030585A2 (en) 2005-06-30
PL211174B1 (pl) 2012-04-30
NZ526904A (en) 2005-07-29
RS51536B (sr) 2011-06-30
JP5074656B2 (ja) 2012-11-14
ME00570B (me) 2011-12-20
CY1106669T1 (el) 2012-05-23
JP2004518655A (ja) 2004-06-24
US20100119471A1 (en) 2010-05-13
US8187588B2 (en) 2012-05-29
KR100874119B1 (ko) 2008-12-15
US20120213816A1 (en) 2012-08-23
EP1343525B1 (en) 2007-04-18
YU49303A (sh) 2006-08-17
PL363220A1 (en) 2004-11-15
US20070020296A1 (en) 2007-01-25
HUP0400687A3 (en) 2004-10-28
WO2002049666A2 (en) 2002-06-27
BG107898A (bg) 2004-08-31
ZA200305545B (en) 2004-10-18
KR20030065556A (ko) 2003-08-06
TWI308872B (en) 2009-04-21
AU2002228993B2 (en) 2006-06-29
CZ307075B6 (cs) 2018-01-03

Similar Documents

Publication Publication Date Title
BR0116249A (pt) Vacina de bacterina de mycoplasma hyopneumoniae aperfeiçoada
BR0310082A (pt) vacina bacteriana de mycoplasma hyopneumonia e melhorada
ES2149361T3 (es) Vacuna viva modificada contra el brsv, mejorada.
AR026940A1 (es) Composicion farmaceuticas para modulacion inmunologica y preparacion de vacunas
DE122010000041I1 (de) Solubilisierung von capsulären Polysacchariden
BR0313775A (pt) aparelho e métodos de serviços da rede
WO2003055513A3 (en) Bacillus subtilis spores to stimulate the immune responses
FR2758334B1 (fr) Composition aqueuse epaissie comprenant un polymere amphiphile et une silicone polyoxyalkylenee et utilisation en cosmetique
ATE392216T1 (de) Mycobakterieller impfstoff
ZA9710606B (en) Non-virulent Mycoplasma synoviae vaccine thereof.
HK1035141A1 (en) Methods and compositions for detection and diagnosis of infectious diseases.
MX9605503A (es) Vacuna mejorada de virus sincitial respiratorio debovino (brsv) vivo, modificado.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: WYETH LLC (US)

B25A Requested transfer of rights approved

Owner name: PAH W LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS W LLC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/06/2016, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B25G Requested change of headquarter approved